Medications

Amgen wins approval for second biotech cholesterol drug

Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.

Genetics

Findings may offer new clues to development of heart disease

Aucklander Cathy McGregor grew up knowing she was "some kind of a miracle baby". When her mother, Robyn, was pregnant with her, her specialist had told her not to expect a live baby. Robyn had been diagnosed with rhesus disease, ...

page 15 from 31